SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950005-10-000210
Filing Date
2010-11-08
Accepted
2010-11-08 16:58:38
Documents
1
Group Members
ALISON KILEYALTA BIOPHARMA MANAGEMENT III, LLCALTA BIOPHARMA PARTNERS III GMBH & CO. BETEILIGUNGS KGALTA BIOPHARMA PARTNERS III, L.P.ALTA EMBARCADERO BIOPHARMA PARTNERS III, LLCEDWARD HURWITZEDWARD PENHOETFARAH CHAMPSIJEAN DELEAGE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D e10104_sc13d.htm SC 13D 139358
  Complete submission text file 0000950005-10-000210.txt   141765
Mailing Address ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111
Business Address ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111 4153624022
ALTA BIOPHARMA PARTNERS III LP (Filed by) CIK: 0001257444 (see all company filings)

IRS No.: 050573803 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807
Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300
Aegerion Pharmaceuticals, Inc. (Subject) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-85739 | Film No.: 101173072
SIC: 2834 Pharmaceutical Preparations